Anas, Jenelyn F.

HRN: 28-77-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2026
CEFTRIAXONE 1G (VIAL)
04/02/2026
04/09/2026
IV
2gm
OD
S/p Wound Suturing
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft TissueProphylaxis    Compliance to guidelines: